Your browser doesn't support javascript.
loading
How to Protect the Vulnerable Groups in Drug Clinical Trials / 中国医学伦理学
Chinese Medical Ethics ; (6): 572-575, 2017.
Artículo en Chino | WPRIM | ID: wpr-619277
ABSTRACT

Objective:

To find a better way to protect the security and interests of vulnerable groups by exploring the problem of protecting the vulnerable groups in drug clinical trial from the perspectives of ethics committees,organization and researchers.

Methods:

According to the relevant literature and the actual situation of the hospital,this paper analyzed the security issues of vulnerable groups comprehensively.

Results:

Only the ethics committees,organization and researchers work together,can it protect the security and interests of vulnerable groups to the greatest extents.

Conclusion:

Further research on the security of vulnerable groups not only promotes the development of human health,but also plays a decisive role in improving the protection of subjects in drug clinical trial.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Medical Ethics Año: 2017 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Medical Ethics Año: 2017 Tipo del documento: Artículo